New selective PAD4 inhibitors binding a calcium-deficient sort of the PAD4 enzyme have validated the important enzymatic position of human and mouse PAD4 in equally histone citrullination and neutrophil extracellular trap development for, to our understanding, the first time. The therapeutic potential of PAD4 inhibitors can now be explored. This https://rodneyz221mwh4.blazingblog.com/profile